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Abstract: Diabetes is a chronic non-communicable disease (NCD) presenting growing
health and economic burdens in sub-Saharan Africa (SSA). Diabetes is unique due to its
cross-cutting nature, impacting multiple organ systems and increasing the risk for other
communicable and non-communicable diseases. Unfortunately, the quality of care for dia-
betes in SSA is poor, largely due to a weak disease management framework and fragmented
health systems in most sub-Saharan African countries. We argue that by synergizing disease-
specific vertical programs with system-specific horizontal programs through an integrated
disease-system diagonal approach, we can improve access, quality, and safety of diabetes
care programs while also supporting other chronic diseases. We recommend utilizing the six
World Health Organization (WHO) health system building blocks – 1) leadership and
governance, 2) financing, 3) health workforce, 4) health information systems, 5) supply
chains, and 6) service delivery – as a framework to design a diagonal approach with a focus
on health system strengthening and integration to implement and scale quality diabetes care.
We discuss the successes and challenges of this approach, outline opportunities for future
care programming and research, and highlight how this approach can lead to the improve-
ment in the quality of care for diabetes and other chronic diseases across SSA.
Keywords: diabetes, sub-Saharan African, integrated diagonal health systems approach,
health system building blocks, health system strengthening, health system integration
Introduction
The global burden of non-communicable disease (NCDs) is staggering, with recent
reports highlighting that NCDs are responsible for 73% of deaths globally, with more
than 50% of these deaths caused by four risk factors: diabetes, hypertension, obesity,
and smoking.1 In sub-Saharan Africa (SSA), diabetes mellitus is estimated to affect
40.7 million people by 2045, up from 15.9 million people in 2017.2 This burden is
further exacerbated by estimates which show that more than two-thirds of individuals
in SSAwith diabetes are undiagnosed.3 Given the increasing demand and inadequate
funding for diabetes care, the quality of care for diabetes in SSA is poor.4 Furthermore,
diabetes carries a significant “double burden” of infectious and chronic diseases.5 It can
increase the risk of other non-communicable conditions such as cardiovascular and
renal disease, as well as communicable conditions such as pneumonia and
tuberculosis.6 As a lifelong illness, diabetes is a multifaceted disease, affectingmultiple
organ systems and characterized by periods of acute exacerbations, requiring a com-
prehensive, cross-cutting, and often high-cost approache to successfully manage.7 To
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provide sustainable, comprehensive diabetes management, it
is essential to integrate disease-specific care programs for
diabetes into all other system-wide functions of the health
system, such as leadership and governance, financing, health
workforce, health information systems, supply chains, and
service delivery.8
The growing demand for diabetes care, the enormous
economic burden diabetes poses, and the cross-cutting
nature of the disease and its ensuing complications all
have major implications for how diabetes care is delivered
in SSA.7,8 We argue that by synergizing disease-specific
vertical programs with system-specific horizontal pro-
grams through an integrated disease-system diagonal
approach, we can improve access, quality, and safety of
diabetes care programs. In order to assess the merits of this
approach for diabetes, we performed a thorough review of
the peer-reviewed literature by querying Pubmed in addi-
tion to websites of reputable global organizations (i.e.
World Bank, World Health Organization [WHO],
International Diabetes Federation [IDF]) to identify evi-
dence describing the relevance of using a diagonal
approach for diabetes care in LMIC settings in SSA. We
utilized the six WHO health system building blocks – 1)
leadership and governance, 2) financing, 3) health work-
force, 4) health information systems, 5) supply chains, and
6) service delivery – as a framework to design a diagonal
approach with a focus on health system strengthening and
integration to implement and scale quality diabetes care.9
We also discuss the successes and challenges of this
approach, outline opportunities for future care program-
ming and research, and highlight how this approach may
lead to the improvement in the quality of care for diabetes
and other chronic diseases across SSA.
Defining The Diagonal Approach To
Health System Strengthening And
Integration
It has been argued that health systems in low- and middle-
income countries (LMICs), including countries within
SSA, are often segmented and fragmented making it diffi-
cult for patients to navigate a divided care system.4,8,10 In
the past, vertical and horizontal approaches to global
health have both been used in health systems planning.11,12
The vertical approach refers to a health system that
focuses on management of a single disease and builds
infrastructure dedicated to managing that particular disease
only.11 This approach is commonly used in LMIC settings
with limited funding to provide immediate response and
management to disease outbreaks due to the relative ease
of setting up as compared to other schemes. Various high-
lights such as the drastic reduction in new HIV cases
through HIV/AIDS control programs or success in polio
eradication programs have led to its popularity.11 On the
contrary, the horizontal approach promotes health services
that strengthen infrastructure and functions of the entire
health system.13 Health programs designed using this
approach are common in developed countries and have
been referred to as “more integrated, demand-driven,
resource sharing health services.”11,14
Vertical and horizontal approaches both have chal-
lenges and shortfalls. On one hand, vertical programs are
often unsustainable in the absence of donor support and
sometimes have detrimental effects on other aspects of the
healthcare system as it draws resources from other aspects
to unilaterally focus on one disease.10,11 On the other
hand, horizontal programs and their impacts are often
diluted by trying to address the myriad issues that health
systems in LMICs face.15 As a result, a diagonal approach
seeks to merge the strengths of the vertical and horizontal
approaches while avoiding many of their disadvantages.16
It combines the immediate advantages of the vertical sys-
tem as well as the long-standing benefits of the horizontal
system.15,17 Through synergistic integration, disease-spe-
cific programs are incorporated in the many health system
functions, leading to overall health system strengthening
and integration.11,18,19
A Proposed Diagonal Approach For
Diabetes Care Implementation And
Scale-Up
Delivering diabetes care in a vertical, disease-specific pro-
gramming and financing model is costly, inefficient, inef-
fective, and unsustainable over the long term. As a result,
a diagonal approach is particularly appealing for diabetes
because of the multiple organ systems it impacts and the
complementarity of its management with the many other
chronic diseases experienced by patients in SSA, as seen
in Figure 1.
Leadership/Governance
Well-rounded leadership and governance are key to main-
taining an effective and sustainable healthcare system. All
individual patients, their families, and health workers can
play leadership roles in health development.20 Yet, many
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countries in SSA lack a clear political leadership and
advocacy framework for diabetes.21
To address inadequate support from governments, a mod-
ified framework on health development governance was sug-
gested to be applied to the WHO African region.20 Strong
public health leadership and management, effective internal
and external partnership for health, efficiency in resource
allocation and use, and community participation and respon-
siveness are critical strategies for strengthening the leadership
and governance structures to improve diabetes care.20 The
Diabetes Action Now campaign initiated by the IDF and the
WHO aimed to improve the effectiveness of surveillance,
prevention, and control of type 2 diabetes, providing strategic
policy direction and oversight at a multi-national level.21 In
Tanzania, theMinistry of Health (MOH) collaborated with the
Tanzanian Diabetes Association to set up a network of dia-
betes clinics throughout the country.21 The significance of the
MOH National Eye Care Plan was also recognized in
Botswana, Ghana, Tanzania, and Zambia for prevention of
diabetic retinopathy.22 Recognizing the heavy burden of
Figure 1 Functional diabetes care system as a framework for comprehensive population health.
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diabetic retinopathy and visual impairment and blindness in
patients in LMICs, the WHO also created a standardized tool
for the assessment of diabetic retinopathy and diabetes man-
agement systems (TADDS).23 This tool is to assist countries
with situation analysis, service provision capability, and iden-
tification of gaps to be addressed to ensure access to diabetes
care and prevention and treatment of diabetic retinopathy. In
addition to the aforementioned strategies directly addressing
health outcomes, policies tackling food availability, cash
crops, and urbanization are equally essential in combating
diabetes.21 Evidence has shown that the risk of diabetes
increases with concomitant micronutrient deficiencies and
the rising issues of malnutrition and unhealthy lifestyle
practices.24 The Integrated Nutrition Program was thus estab-
lished in South Africa to reduce nutrition-related diseases of
lifestyle such as type 2 diabetes.25
TheWHO also established the Global Action Plan for the
Prevention and Control of NCDs to reduce death caused by
cardiovascular diseases, chronic respiratory diseases, can-
cers, and diabetes by 25% by 2025.26 The WHO utilizes
national-level taxes and legislation, and leverages the experi-
ence of HIV/AIDS health programs to combat tobacco use,
harmful use of alcohol, physical inactivity, and unhealthy
diet.26 Taking the socioeconomic determinants of diabetes
into account can help resolve the fundamental causes of
health disparities. Leveraging multinational entities such as
the WHO and IDF can strengthen the leadership and govern-
ance structure for the advancement of the entire health
system.
An integrated and comprehensive approach to diabetes
management cannot overlook issues surrounding social
determinants of health (SDH), a concept spearheaded by
the WHO. SDH are the conditions in which “people are
born, grow, work, live, and age, and the wider set of forces
and systems shaping the conditions of daily life.”27 Time
and time again, SDH such as low income, low educational
attainment, employment insecurity, poor living conditions,
inconsistent access to nutritious food, essential medica-
tions and supplies are demonstrated to play a key role in
the development and progression of diabetes worldwide.28
Focusing on biological and behavioral factors alone, with-
out addressing SDH and their impact on diabetes burden
will not adequately address diabetes management, and will
continue to present as a barrier to the improvement of
diabetes. The WHO Commission on SDH (CSDH) has
been fighting for equity and fair distribution of health
care resources since 2005. However, patients living with
diabetes and their family members must also demand and
advocate with their providers, their communities, and their
health authorities to provide the physical and mental health
resources to enable them to better manage their care needs.
Diagonally incorporating diabetes care into the broader
health system can promote leadership and governance to
address the broad spectrum of diabetes as effective inter-
ventions for all of these diseases require comprehensive
interventions which consider socioeconomic, nutritional,
and environmental perspectives in SSA.
Financing
The financing of diabetes care has created a heavy burden
on both the society and individual patients. Unlike HIV,
TB, and malaria which received more than 99% of the
healthcare assistance from the US to LMICs in 2010,
diabetes receive only limited outside assistance.29 While
it is clear that diabetes care in SSA would greatly benefit
from a coordinated response similar to what was seen with
HIV through the President’s Emergency Plan for AIDS
Relief (PEPFAR), it is unlikely to happen and creative
locally financed solutions must be sought.
The economic burden of diabetes includes direct costs
due to healthcare and indirect costs due to workforce
losses.30 The total economic loss in SSA was more than
11 billion dollars with 56.9% of it as direct costs and
43.1% as indirect costs.30 The high rate of indirect costs
in SSA can be explained by the peak prevalence in the age
groups of 20 to 44 and 45 to 64 years in SSA, affecting the
most economically productive portion of the population.30
This double burden of diseases on people of working ages
aggravates the economic impact of diabetes similar to HIV
during the height of epidemic in SSA.
The costs of treatment for diabetes and its complications
are significant as well. To treat diabetes itself, the cost of a
10 mL 100 IU/mL vial of insulin can range from $4.10 to
$8.40.31 The monthly cost of routine diabetes care is US$
21.2 in Mali, accounting for almost 70% of the mean
income.32 In Nigeria, the monthly direct cost of routine
diabetes care for children and adolescents was around US
$73 with insulin making up 51.5% of it.33 Diabetes treat-
ment costs can reach more than twice the non-food expen-
diture per month in the poorest quartile of the patient
population in Nigeria.34 For oral hypoglycemic agents spe-
cifically, a monthly regimen of metformin would cost more
than 3 days’worth of wages in Kenya and more than 6 days’
worth of wages in Ghana.35 On top of the treatment costs for
diabetes, the cost of care for its complications can also be
overwhelming as diabetes uniquely affects multiple organ
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systems as seen in Figure 1. Some common complications
and comorbidities include infectious diseases, neurological,
cardiopulmonary, gastrointestinal, renal, genitourinary, der-
matological, and pregnancy conditions.7 These complica-
tions can add considerable cost. For example, to treat
cardiovascular diseases, a monthly course of aspirin, a
statin, a beta-blocker, and an ACE inhibitor can cost 18
days’worth of wages in Malawi.36 The cost of treatment for
complications and comorbidities can outweigh that of pri-
mary and secondary prevention of diabetes.37 The total
treatment costs for diabetes and its complications thus
become a leading barrier for patients to receive proper,
comprehensive diabetes care.38 As described above, the
high out-of-pocket healthcare payments, loss of family-
income-associated disability, premature death, in addition
to expenditure on daily medications and treatments of dia-
betic complications due to being uninsured are major
sources of catastrophic expenditures imposed on diabetic
patients without financial protection for themselves and
their family members.
While some efforts have provided short-term support for
the immediate needs of patients with diabetes, the long-term
needs of patients with diabetes could be better managed
through integration within the broader health system. The
high cost of providing comprehensive care for diabetes
requires risk mitigation which can be achieved through inclu-
sion within broader population-level insurance programs
which cover both sick and non-sick enrollees. As described
earlier, the costs of diabetes care to the individual are unten-
able for many patients in need of care. However, through
novel risk mitigation strategies, this cost could be spread
across a much larger population of sick and non-sick popula-
tions through governmentally backed universal health cover-
age programs which aim to provide health coverage to all
citizens.39 The ultimate aims of universal health coverage are
to cover beneficiaries, maximize financial protection, and
protect individuals from catastrophic health expenditures.40
Despite the growing popularity of universal health coverage
in policy discussions, less than 10% of the population in SSA
is covered under these schemes and there has been limited
translation of policy into patient impact.39 Even though few
examples exist within SSAwith regard to successful financial
protection schemes for patients living with diabetes, exam-
ples from a recent report demonstrate initial successes with
innovative financial protection programs such as the health
equity funds for the poor initiative in Cambodia or the uni-
versal health coverage scale-up initiative in Kenya, Turkey,
Mexico, Thailand, and China.41
The economic burden of diabetes on individuals and
society is substantial. Isolated, vertical funding for dia-
betes alone is not sustainable. One potential pathway for
resolving these issues is to leverage the infrastructure and
resources needed to address the multiple complications of
diabetes to support an integrated chronic disease care
system, which is responsive to many emerging healthcare
needs in SSA. Other potential pathways include the crea-
tion of insurance plans that insure against long-term cost
of diabetes, compulsory social health insurance programs,
tax-based financing insurance programs, subsidies for
healthy substitutes, or population-based targeted interven-
tions (i.e. taxes on alcohol, tobacco, sweetened
beverages).41 Through this diagonal approach, the costs
and benefits of diabetes can also be shared across a much
larger pool of patients. This approach could reduce the
costs of care per patient by maximizing the economies of
scale within the healthcare system.
Health Workforce
A severe shortage of trained healthcare providers is
observed in many SSA countries,42,43 with an average of
15.5 physicians per 100,000 people in SSA,42 compared to
245 physicians per 100,000 people in the United States in
2011.44 In 2010, Tanzania has a physician density of 0.6 per
100,000 people, Liberia (1.2), Ethiopia (2.3), Ghana (8.0),
Congo (9.2), and Nigeria (32.8).45 The Health, Nutrition,
and Population Project in Malawi conducted between 1991
and 2000 concluded that imbalanced and understaffed facil-
ities can lead to poor quality of healthcare.46 In addition, it
has been documented that healthcare workers’ capacity to
manage diabetes is still suboptimal in various countries
across SSA with regard to training, diagnosis capability,
knowledge about treatment protocols and medication pre-
scriptions, as well as management of complications and
comorbidities of diabetes.47
One of the solutions to improve the health workforce
shortage and quality of care is task shifting. Task shifting
is defined as delegating tasks to workers with narrow,
specific training for a particular task.48 Task shifting can
increase productivity, reduce training time, increase
patients’ access to healthcare, and improve quality of
care.48 Training other healthcare professionals for certain
aspects of diabetes care can help achieve the aforemen-
tioned goals due to the cross-cutting nature of the disease.
Through shifting the more time-intensive routine care
activities to other members of the healthcare team, physi-
cians can concentrate their efforts on patients with
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complications who need more in-depth review and treat-
ment from providers with extensive clinical experience.
For example, to better manage diabetes-associated
complications and comorbidities, peers or community
health workers trained to monitor blood glucose levels
could also be cross-trained to monitor blood pressure,
conduct other point-of-care testing, or even prescribe or
adjust medications. The efficacy of this approach has been
consistently documented across SSA.49 The relationship
established between patients and community health work-
ers can further strengthen patient engagement in their
health decision-making and connect the rural communities
with health systems.50 Moreover, in rural South Africa, the
Hlabisa project found that nurse-led care was associated
with positive outcomes in glucose management given
well-defined protocols.51 Nurse-led diabetes care success-
fully decreased A1C levels by 33% from baseline in 18
months of time.52 The creation of a community peer leader
program for diabetes care has also demonstrated improved
levels of A1C and systolic blood pressure.53 Nutritionists
and dietitians represent another vital component of the
diabetes healthcare team that must be effectively incorpo-
rated to introduce contextualized culturally appropriate
guidance to optimize the prevention and management of
diabetes in SSA.54
Given above examples of several cadres of health
workers working in isolation to improve the quality of
diabetes care, it must be noted that real-world examples
have shown that despite significant barriers such as hier-
archal structure and time and financial resource con-
straints, creating interdisciplinary teams of health
professionals (i.e. doctors, nurses, dieticians, nutritionists)
and social scientists (i.e. anthropologists, psychologists,
sociologists) is possible and can improve treatment out-
comes for patients living with diabetes.55
In addition to task shifting, integrating diabetes care into
the broader health system leverages the existing workforce
to provide comprehensive healthcare. It is more cost-effec-
tive to train existing healthcare providers than to hire new
ones. Home-based HIV counselors in Kenya have been
trained to also screen for diabetes and hypertension in the
community.56 As a result, due to the cross-cutting nature of
disease, a healthcare workforce that is trained to manage
diabetes and its complications could also manage a wide
variety of other diseases frequently found throughout the
population (Figure 1). The integration of diabetes care into
the broader health system using a diagonal approach can
promote universal patient access to a trained healthcare
workforce and lead to improvement of quality of care across
SSA.
Health Information Systems
High-quality treatment for diabetes and its associated com-
plications and comorbidities requires sophisticated infor-
mation management systems. However, in most SSA
countries, there is limited access to electronic health infor-
mation systems (EHIS). Several challenges and barriers
have been identified, including high cost of set-up and
maintenance, poor network infrastructure, and lack of
comfort among the users.57 Consequently, many health
systems in South Africa still use paper-based documenta-
tion systems, which can lead to poor patient care.58
To improve patient health outcomes, workflow efficien-
cies, and cost-effectiveness, the establishment of an EHIS is
vital.59 Various technologies have been developed to
advance EHIS, such as electronic medical records, teleme-
dicine, e-Health, and computerized clinical decision-sup-
port systems.59 Telemedicine and electronic health record
have been shown to reduce overall healthcare cost in South
Africa and Kenya, respectively.60,61 More specifically, the
implementation of EHIS for diabetes care can lead to
improved diabetes quality metrics, including an increase
in the percentage of patients receiving annual A1C, blood
pressure, lipid, foot, urine, and eye examinations in
LMICs.62 Additionally, the use of electronic records can
reduce prescription errors, flag abnormal laboratory results,
and allow access to patients records by multiple viewers.57
All the aforementioned technologies can provide timely and
accurate information on individual patients, which is criti-
cal in organizing the provision of comprehensive care of
diabetes.63 In addition to improving clinical services, EHIS
can support data collection for monitoring, evaluation, qual-
ity improvement, and research purposes. EHIS are gener-
ally not disease-specific, but rather function to support the
information needs of the entire health system. In Rwanda,
an electronic medical record system was implemented to
serve all patients with HIV/AIDS, tuberculosis, hyperten-
sion, diabetes, and other chronic conditions.64 And because
of the cross-cutting nature of diabetes, the implementation
of an EHIS will not only benefit care for diabetes, but also
the quality of care for other related conditions such as
cardiovascular diseases, renal diseases, and various types
of infectious diseases. It is therefore essential to take a
diagonal approach, integrating diabetes care into a broader
health system strengthening effort, catalyzing the advance-
ment of electronic health information infrastructure in SSA
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more generally. An integrated EHIS provides the seamless
clinical and programmatic data required to effectively care
for diabetes and other associated illnesses across the disease
continuum and throughout the life course. Scaling up dia-
betes care via a diagonal, health systems approach helps
promote the advancement of EHIS for the benefit of the
health system as a whole, while simultaneously improving
the quality of care for diabetes.
In addition to EHIS, SSA has been able to establish its
own Africa Health Observatory as part of the WHO initia-
tive – Global Health Observatory (GHO).65 With this rich
data source, many countries in SSA participate to regularly
share real-time data on global health indicators, including
data, statistics, health situation analysis by country, and
information about diseases and health indicators. Besides
EHIS, investing in a transparent health information sys-
tems such as the Africa Health Observatory increases the
accountability and quality of collected data, while also
providing updated information on disease epidemiology,
health indicators, and infrastructure indicators, EHIS and
global health observatories present as an efficient alloca-
tion of financial resources to address diabetes in SSA.
Supply Chains
Access to essential medications and diagnostic tests is a
vital element for the delivery of high quality of care for
patients in SSA. To provide effective therapies for both
communicable and NCDs, many countries have estab-
lished the national Essential Medicines List (EML).66
Even with the list, the average drug availability in public
sector facilities in SSA is merely 38.2%.35 When medica-
tions are not available in the public sector, patients would
have to either forgo the treatments or go to the private
sectors for higher-priced drugs, where availability is still
not guaranteed.
Essential treatment modalities of diabetes and its compli-
cations are composed of various classes of medications,
including insulin and oral hypoglycemics, anti-hypertensives,
statins, and aspirin. However, almost 20% of the anti-hyper-
tensive medications found in Rwanda were substandard and
70% of them had poor stability.67 Some patients may need
insulin as well, which presents life-threatening challenges to
patients who depend on insulin to survive.68 The International
Insulin Foundation has conducted studies in Zambia,Mali, and
Mozambique and found the causes of barriers to accessing
essential medicines can be linked not only to affordability and
accessibility issues, but also to issues related to access to
syringes, diagnostic tools, and medications for diabetes-
associated comorbidities.69 In terms of diagnostic capacity,
only 6% of health centers in Mozambique were qualified to
test blood glucose.69 To effectively manage diabetes, diagnos-
tics for other parameters such as blood pressure, lipid panels,
and renal function tests are also required. The WHO accord-
ingly suggested to combine management of diabetes, cardio-
vascular disease, and evenHIV/AIDS and tuberculosis to yield
superior health outcomes.7
All these impediments reinforce the importance of
establishing a robust, consistent, and high-quality supply
chain to deliver medications, supplies, and diagnostic tools
for comprehensive diabetes care. Due to the complexity of
diabetes, its supply chains should be integrated into the
whole health system rather than for disease-specific enti-
ties. Building a supply chain solely for insulin or syringes
is not sustainable and cost-effective. One innovative solu-
tion that can provide a back-up supply of medications
when public-sector supply chains break down is the
Revolving Drug Fund (RDF) model that has been imple-
mented in multiple SSA countries.70 Within the Kenyan
implementation, the RDF provides sustainable access to
medications when government pharmacies are out of
stock, and has been shown to increase medication avail-
ability by at least 50%.71 Comprehensive diabetes care
requires multifactorial interventions including sustainable
access to medications, medical supplies, and diagnostic
tools for blood sugar, lipid, and renal function testing.
With appropriate use of medications and medical supplies,
the burden of diabetes can be significantly reduced.
Consequently, it is imperative to integrate supply chains
for diabetes medicines and supplies with those for other
essential medicines in order to effectively ameliorate dis-
parities in access to essential medicines for all chronic
diseases.
Service Delivery
Strengthening health service delivery is critical in provid-
ing sustainable, comprehensive, and cost-effective diabetes
care. In Cape Town, South Africa, the quality of care was
poor for the delivery of diabetes care.72 Renal function
tests were only performed in 39.5% of the cases and
HbA1C was only tested for 37% of the patients.72 In
Kenya, the quality of diabetes care was also poor at
various levels of the healthcare system, and less than
20% of the patients achieved controlled A1C levels.73
The challenges of establishing efficient and effective ser-
vice delivery mechanisms for diabetes care are the lack of
an adequate health care workforce, evidence-based
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guidelines, medical supplies, diagnostic tools, and first-
line medications.74 In Tanzania, only 13% of the facilities
have well-developed guidelines to assist less-specialized
and educated clinicians to provide diabetes care.74
To improve the quality of care for diabetes, evidence
suggests that integrating service delivery with screening,
education, and care for other chronic illnesses can be the
solutions. Recently, this has been attempted through various
Universal Health Coverage initiatives through primary
healthcare strengthening in SSA countries including Kenya,
Rwanda, Zambia, Ghana, Ethiopia, and others. Even though
essential care services have been expanded significantly,
compared to other WHO regions, SSA still has the lowest
performance on tracer indicators of coverage of essential
services.39 However, progress continues to be made through
screening programs for diabetes in Uganda, through which
diabetes screening was integrated into existing community-
wide HIV testing facilities, which promoted patient engage-
ment in healthcare.75 Multi-disease testing in community
settings offers advantages by providing patient access to
comprehensive treatment options and screening in the rural
areas, which further improves health outcomes.75,76 It addi-
tionally has been shown to reduce stigma experienced by
patients with HIV/AIDS.75 Furthermore, in eight African
countries including Tanzania, Cameroon, Mozambique,
Kenya, Uganda, Senegal, Zimbabwe, and Zambia, the IDF
Figure 2 WHO health system building blocks as a framework for functional diabetes care system.
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established standardized education for diabetes awareness
and patient self-management.77 Patients also tend to move
between primary, secondary, and tertiary care facilities due to
the complexity and severity of diabetes-associated complica-
tions or comorbidities.78 To improve service delivery for
diabetes care, it is therefore essential to simultaneously
address the intertwining challenges and concerns from all
of the WHO building blocks as diabetes care requires cross-
cutting interventions and a well-functioning, comprehensive
health system at multiple levels. Integrating diabetes care
through a diagonal health systems strengthening approach
is a promising solution to the inefficient and poor quality of
service delivery that is the current reality in SSA.
Potential Use Of The Diagonal
Approach To Address Other NCD
Care Programs
As outlined in Figure 2, we utilize the six World Health
Organization (WHO) health system building blocks – lea-
dership and governance, financing, health workforce,
health information systems, supply chains, and service
delivery – as a framework for addressing the importance
of implementing and scaling diabetes care within a diag-
onal approach focused on health system strengthening. We
discuss the successes and challenges of this approach,
outline opportunities for future care programming and
research, and highlight how this approach may lead to
the improvement in the quality of care for diabetes and
other chronic diseases across SSA. These challenges and
potential solutions are summarized in Table 1, which helps
illustrate how an effective response to diabetes-related
challenges could simultaneously help address the needs
for other NCDs.
Conclusions
This paper illustrates the benefits, importance, and urgency
of diagonally integrating diabetes care into the broader
health system in order to improve the quality of care for
diabetes and also other chronic illnesses. This diagonal
approach has positive impacts on all six of the WHO
health system building blocks, and simultaneously, addres-
sing barriers and challenges in each of these critical health
system functions is necessary to provide comprehensive,
Table 1 Shared Challenges Between Diabetes And Other NCDs In SSA, Potential Solutions Through The Use Of A Diagonal
Approach And Feasibility
Shared Challenges Between Diabetes And
Other NCDs In SSA
Potential Solutions Feasibility
Limited translation of policy declarations into
tangible improvements in patient outcomes
Introduce policies which holistically address the drivers of
NCDs and link policy advocacy to appropriate resource
allocation
High (long-term impact)
Increasing burden of disease Implementation of comprehensive prevention and awareness
programs
High (long-term impact)
Lack of efforts to introduce vertical programs to
address specific NCDs
Utilize a diagonal approach that improves the responsiveness
of the health system to NCDS
High (long-term impact)
Complications of diseases impact multiple organ
systems
NCD care benefits from enhancements in care designed to
address diabetes complications
High (long-term impact)
Limited funding from national governments to
specifically address NCDs
Incorporation of NCDs within government-backed universal
health coverage programs which distribute costs across the
entire population
High (immediate impact)
Inefficient, ineffective supply chain systems with
limited access to vital commodities
Introduction of novel supply chain systems which subsidize
costs and ensure uninterrupted availability
High (immediate impact)
Limited availability of a formally trained health
workforce capable of managing the growing
population with these diseases
Scale-up of task-shifted models for chronic disease service
delivery which align the acuity of patient needs with the
appropriate level of provider
High (immediate impact)
Poorly organized data for NCDs Introduction of electronic health information systems to
improve tracking, quality of care, and planning
High (immediate impact)
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high-quality care for a cross-cutting, complex, lifelong
disease such as diabetes. The incorporation of diabetes
care can strengthen existing health systems in SSA
through policy prioritization, innovative financing
mechanisms, task-shifting of workforce, EHIS, seamless
and secure access to essential medicines and diagnostic
tools, and comprehensive service delivery. More impor-
tantly, this new model of care for diabetes attempts to
integrate a social-medical-preventive approach to a histor-
ical bio-medical-curative approach, and has the promise to
not only enhance the biological outcomes but also social
outcomes for patients living with diabetes. The long-term
goal of integrating sustainable care for diabetes and its
associated complications into all the vital health system
functions is to improve health outcomes for all patient
populations in SSA.
Acknowledgments
There was no specific funder for this manuscript. TM, AG,
JL, SP work with the Academic Model Providing Access
to Healthcare (AMPATH), which is supported by the
President’s Emergency Plan for AIDS Relief (PEPFAR)
through the United States Agency for International
Development (USAID) under the terms of Cooperative
Agreement No. AID-623-A-12-0001. The contents of this
manuscript are the sole responsibility of the authors and do
not necessarily reflect the views of USAID or the United
States Government.
Disclosure
SP serves as a consultant for Abbott but this activity is
unrelated to the work described in this paper. The authors
report no other conflicts of interest in this work.
References
1. GBD 2017 Risk Factor Collaborators. Global, regional, and national
comparative risk assessment of 84 behavioural, environmental and
occupational, and metabolic risks or clusters of risks for 195 countries
and territories, 1990-2017: a systematic analysis for the Global Burden
of Disease Study 2017. Lancet Lond Engl. 2018;392(10159):1923–
1994. doi:10.1016/S0140-6736(18)32225-6
2. International Diabetes Federation. Regional fact sheet: Africa | World
Diabetes Foundation. Available from: https://www.worlddiabetesfoun
dation.org/files/regional-fact-sheet-africa. 2017. Accessed February
26, 2019.
3. Assah F, Mbanya JC. Diabetes in sub-Saharan Africa. In: Dagogo-Jack
S, editor. Diabetes Mellitus in Developing Countries and Underserved
Communities. Cham: Springer International Publishing; 2017:33–48.
doi:10.1007/978-3-319-41559-8_3
4. Atun R, Davies JI, Gale EAM, et al. Diabetes in sub-Saharan Africa:
from clinical care to health policy. Lancet Diabetes Endocrinol.
2017;5(8):622–667. doi:10.1016/S2213-8587(17)30181-X
5. de-Graft Aikins A, Unwin N, Agyemang C, Allotey P, Campbell C,
Arhinful D. Tackling Africa’s chronic disease burden: from the local
to the global. Glob Health. 2010;6:5. doi:10.1186/1744-8603-6-5
6. International Diabetes Federation - Complications. Available from:
https://www.idf.org/aboutdiabetes/complications.html. Accessed July
9, 2019.
7. World Health Organization. WHO Global Report on Diabetes. WHO.
2016. Available from: http://www.who.int/diabetes/global-report/en/.
Accessed February 27, 2019.
8. Pastakia SD, Pekny CR, Manyara SM, Fischer L. Diabetes in sub-
Saharan Africa – from policy to practice to progress: targeting the
existing gaps for future care for diabetes. Diabetes Metab Syndr Obes
Targets Ther. 2017;10:247–263. doi:10.2147/DMSO.S126314
9. World Health Organization, ed. Monitoring the Building Blocks of
Health Systems: A Handbook of Indicators and Their Measurement
Strategies. Geneva: World Health Organization; 2010.
10. Knaul FM, Bhadelia A, Atun R, Frenk J. Achieving effective uni-
versal health coverage and diagonal approaches to care for chronic
illnesses. Health Aff Proj Hope. 2015;34(9):1514–1522. doi:10.1377/
hlthaff.2015.0514
11. Orenstein WA, Seib K. Beyond vertical and horizontal programs: a
diagonal approach to building national immunization programs
through measles elimination. Expert Rev Vaccines. 2016;15
(7):791–793. doi:10.1586/14760584.2016.1165614
12. World Health Organization. WHO | Vertical–Horizontal Synergy of
the Health Workforce. WHO. 2005. Available from: https://www.
who.int/bulletin/volumes/83/4/editorial10405/en/. Accessed February
28, 2019.
13. Frenk J. Bridging the divide: global lessons from evidence-based
health policy in Mexico. Lancet Lond Engl. 2006;368(9539):954–
961. doi:10.1016/S0140-6736(06)69376-8
14. Sepúlveda J, Bustreo F, Tapia R, et al. Improvement of child
survival in Mexico: the diagonal approach. Lancet Lond Engl.
2006;368(9551):2017–2027. doi:10.1016/S0140-6736(06)69569-X
15. Uplekar M, Raviglione MC. The “vertical-horizontal” debates: time
for the pendulum to rest (in peace)? Bull World Health Organ.
2007;85(5):413–414. doi:10.2471/blt.07.041756
16. Frenk J. Bridging the divide: comprehensive reform to improve
health in Mexico. Lect WHO Comm Soc Determinants Health
Nairobi. 2006;17.
17. Ooms G, Van Damme W, Baker BK, Zeitz P, Schrecker T. The
“diagonal” approach to global fund financing: a cure for the broader
malaise of health systems? Glob Health. 2008;4:6. doi:10.1186/1744-
8603-4-6
18. Gounder CR, Chaisson RE. A diagonal approach to building
primary healthcare systems in resource-limited settings: women-
centred integration of HIV/AIDS, tuberculosis, malaria, MCH and
NCD initiatives. Trop Med Int Health TM IH. 2012;17(12):1426–
1431. doi:10.1111/j.1365-3156.2012.03100.x
19. Hagan JE, Greiner A, Luvsansharav U-O, et al. Use of a diag-
onal approach to health system strengthening and measles elim-
ination after a large nationwide outbreak in Mongolia. Emerg
Infect Dis. 2017;23:13. doi:10.3201/eid2313.170594
20. Kirigia JM, Kirigia DG. The essence of governance in health devel-
opment. Int Arch Med. 2011;4:11. doi:10.1186/1755-7682-4-11
21. Beran D, Yudkin JS. Diabetes care in sub-Saharan Africa. Lancet
Lond Engl. 2006;368(9548):1689–1695. doi:10.1016/S0140-6736
(06)69704-3
22. Poore S, Foster A, Zondervan M, Blanchet K. Planning and devel-
oping services for diabetic retinopathy in Sub-Saharan Africa. Int J
Health Policy Manag. 2015;4(1):19–28. doi:10.15171/ijhpm.2015.04
Mercer et al Dovepress
submit your manuscript | www.dovepress.com
DovePress
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019:122270
23. WHO | Tool for assessment of diabetes and diabetic retinopathy.
WHO. Available from: http://www.who.int/blindness/publications/
tadds/en/. Accessed July 9, 2019.
24. Cooke JG. Public health in Africa – a report of the CSIS global health
policy center. J Public Health Afr. 2010;1:1. doi:10.4081/jphia.2010.e8
25. Labadarios D, Steyn NP, Mgijima C, Daldla N. Review of the South
African nutrition policy 1994-2002 and targets for 2007: achieve-
ments and challenges. Nutr Burbank Los Angel Cty Calif. 2005;21
(1):100–108. doi:10.1016/j.nut.2004.09.014
26. Naik R, Kaneda T. Noncommunicable Diseases in Africa: Youth are
Key to Curbing the Epidemic and Achieving Sustainable Development.
Population Reference Bureau; 2015:12. Available from: www.prb.org.
27. WHO | About Social Determinants of Health. WHO; 2019.
Available from: http://www.who.int/social_determinants/sdh_defini
tion/en/. Accessed July 9, 2019.
28. Hill J, Nielsen M, Fox MH. Understanding the social factors that
contribute to diabetes: a means to informing health care and social
policies for the chronically ill. Perm J. 2013;17(2):67–72. doi:10.
7812/TPP/12-099
29. Engelgau MM, Rosenthal JP, Newsome BJ, Price L, Belis D, Mensah
GA. Noncommunicable diseases in low- and middle-income coun-
tries. Glob Heart. 2018;13(2):131–137. doi:10.1016/j.gheart.2018.05.
001
30. Kirigia JM, Sambo HB, Sambo LG, Barry SP. Economic burden of
diabetes mellitus in the WHO African region. BMC Int Health Hum
Rights. 2009;9:6. doi:10.1186/1472-698X-9-6
31. Beran D, Ewen M, Laing R. Constraints and challenges in access to
insulin: a global perspective. Lancet Diabetes Endocrinol. 2016;4
(3):275–285. doi:10.1016/S2213-8587(15)00521-5
32. Beran D, McCabe A, Yudkin JS. Access to medicines versus access
to treatment: the case of type 1 diabetes. Bull World Health Organ.
2008;86(8):648–649. doi:10.2471/blt.07.048710
33. Onyiriuka N, Ezomo O, Onyiriuka R. Cost of treating Insulin-requir-
ing diabetes in children and adolescents. Journal of Institute of
Medicine. 2013;34(1):2–8. doi:10.3126/jiom.v34i1.9115
34. Okoronkwo IL, Ekpemiro JN, Okwor EU, Okpala PU, Adeyemo FO.
Economic burden and catastrophic cost among people living with type2
diabetes mellitus attending a tertiary health institution in south-east zone,
Nigeria. BMC Res Notes. 2015;8:527. doi:10.1186/s13104-015-1489-x
35. Health Action International and World Health Organization.Medicine
Prices, Availability, Affordability & Price Components. Available
from: http://www.haiweb.org/medicineprices/2017Medicine Prices,
Availability, Affordability & Price Components Available from:
http://www.haiweb.org/medicineprices/Accessed February 28, 2019.
36. Mendis S, Fukino K, Cameron A, et al. The availability and afford-
ability of selected essential medicines for chronic diseases in six low-
and middle-income countries. Bull World Health Organ. 2007;85
(4):279–288. doi:10.2471/BLT.06.033647
37. Hall V, Thomsen RW, Henriksen O, Lohse N. Diabetes in Sub
Saharan Africa 1999–2011: epidemiology and public health implica-
tions. A systematic review. BMC Public Health. 2011;11:564.
doi:10.1186/1471-2458-11-564
38. Alouki K, Delisle H, Besançon S, et al. Simple calculator to estimate
the medical cost of diabetes in sub-Saharan Africa. World J Diabetes.
2015;6(16):1312–1322. doi:10.4239/wjd.v6.i16.1312
39. The World Bank. Tracking Universal Health Coverage: 2017 Global
Monitoring Report. The World Bank; 2017:1–88. Available from:
http://documents.worldbank.org/curated/en/640121513095868125/
Tracking-universal-health-coverage-2017-global-monitoring-report.
Accessed February 28, 2019.
40. World Health Organization. WHO | Health Systems Financing: The
Path to Universal Coverage. WHO; 2010. Available from: /entity/
whr/2010/en/index.html.
41. Jan S, Laba T-L, Essue BM, et al. Action to address the household
economic burden of non-communicable diseases. Lancet Lond Engl.
2018;391(10134):2047–2058. doi:10.1016/S0140-6736(18)30323-4
42. Liese BH, Dussault G. The State of the Health Workforce in Sub-
Saharan Africa. Evidence of Crisis and Analysis of Contributing
Factors. 2004. Available from: http://documents.worldbank.org/
curated/en/412051468002680722/The-State-of-the-health-workforce-
in-Sub-Saharan-Africa-evidence-of-crisis-and-analysis-of-contribut
ing-factors
43. Global Health Workforce Alliance and World Health Organization. A
Universal Truth: No Health Without a Workforce. Third Global Forum
on Human Resources for Health Report. 2013:104. Available from:
https://www.who.int/workforcealliance/knowledge/resources/hrhre
port2013/en/. Accessed February 28, 2019.
44. Central Intelligence Agency. Field Listing: physicians density — the
world factbook. Available from: https://www.cia.gov/library/publica
tions/resources/the-world-factbook/fields/359.html. Accessed February
28, 2019.
45. Tankwanchi ABS, Ozden C, Vermund SH. Physician emigration from
sub-Saharan Africa to the United States: analysis of the 2011 AMA
physician masterfile. PLoS Med. 2013;10(9):e1001513. doi:10.1371/
journal.pmed.1001513
46. The World Bank. Malawi – Population, Health and Nutrition Project.
The World Bank; 2001. 63. Available from: http://documents.world
bank.org/curated/en/278651468300680324/Malawi-Population-
Health-and-Nutrition-Project. Accessed February 28, 2019..
47. Nuche-Berenguer B, Kupfer LE. Readiness of sub-Saharan Africa
healthcare systems for the new pandemic, diabetes: a systematic review.
J Diabetes Res. 2018;2018:9262395. doi:10.1155/2018/9262395
48. Fulton BD, Scheffler RM, Sparkes SP, Auh EY, Vujicic M, Soucat A.
Health workforce skill mix and task shifting in low income countries:
a review of recent evidence. Hum Resour Health. 2011;9:1. doi:10.
1186/1478-4491-9-1
49. Webel AR, Okonsky J, Trompeta J, Holzemer WL. A systematic
review of the effectiveness of peer-based interventions on health-
related behaviors in adults. Am J Public Health. 2010;100(2):247–
253. doi:10.2105/AJPH.2008.149419
50. Smith DL, Bryant JH. Building the infrastructure for primary health
care: an overview of vertical and integrated approaches. Soc Sci Med
1982. 1988;26(9):909–917.
51. Gill GV, Price C, Shandu D, Dedicoat M, Wilkinson D. An effective
system of nurse-led diabetes care in rural Africa. Diabet Med J Br
Diabet Assoc. 2008;25(5):606–611. doi:10.1111/j.1464-5491.2008.02
421.x
52. Lekoubou A, Awah P, Fezeu L, Sobngwi E, Kengne AP. Hypertension,
diabetes mellitus and task shifting in their management in sub-Saharan
Africa. Int J Environ Res Public Health. 2010;7(2):353–363.
doi:10.3390/ijerph7020353
53. Park PH, Wambui CK, Atieno S, et al. Improving diabetes manage-
ment and cardiovascular risk factors through peer-led self-manage-
ment support groups in Western Kenya. Diabetes Care. 2015;38(8):
e110–e111. doi:10.2337/dc15-0353
54. Lupafya PC, Mwagomba BLM, Hosig K, Maseko LM, Chimbali H.
Implementation of policies and strategies for control of noncommunic-
able diseases in Malawi: challenges and opportunities. Health Educ
Behav Off Publ Soc Public Health Educ. 2016;43(1Suppl):64S–9S.
doi:10.1177/1090198115614313
55. McGill M, Blonde L, Chan JCN, et al. The interdisciplinary team in
type 2 diabetes management: challenges and best practice solutions
from real-world scenarios. J Clin Transl Endocrinol. 2017;7:21–27.
doi:10.1016/j.jcte.2016.12.001
56. Pastakia SD, Ali SM, Kamano JH, et al. Screening for diabetes and
hypertension in a rural low income setting in western Kenya utilizing
home-based and community-based strategies. Glob Health.
2013;9:21. doi:10.1186/1744-8603-9-21
57. Akanbi MO, Ocheke AN, Agaba PA, et al. Use of electronic health
records in sub-Saharan Africa: progress and challenges. J Med Trop.
2012;14(1):1–6.
Dovepress Mercer et al
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019:12 submit your manuscript | www.dovepress.com
DovePress
2271
58. Cline GB, Luiz JM. Information technology systems in public sector
health facilities in developing countries: the case of South Africa.
BMC Med Inform Decis Mak. 2013;13:13. doi:10.1186/1472-6947-
13-13
59. Chaudhry B, Wang J, Wu S, et al. Systematic review: impact of
health information technology on quality, efficiency, and costs of
medical care. Ann Intern Med. 2006;144(10):742–752. doi:10.7326/
0003-4819-144-10-200605160-00125
60. Braitstein P, Einterz RM, Sidle JE, Kimaiyo S, TierneyW. “Talkin' about
a revolution”: how electronic health records can facilitate the scale-up of
HIV care and treatment and catalyze primary care in resource-con-
strained settings. J WHOAcquir Immune Defic Syndr 1999. 2009;52
(Suppl 1):S54–S57. doi:10.1097/QAI.0b013e3181bbcb67
61. Keeton C. Measuring the impact of e-health. Bull World Health
Organ. 2012;90(5):326–327. doi:10.2471/BLT.12.020512
62. Ali MK, Shah S, Tandon N. Review of electronic decision-support
tools for diabetes care: a viable option for low- and middle-income
countries? J Diabetes Sci Technol. 2011;5(3):553–570. doi:10.1177/
193229681100500310
63. Glasgow RE, Orleans CT, Wagner EH. Does the chronic care model
serve also as a template for improving prevention? Milbank Q.
2001;79(4):579–612, iv-v.
64. Mutale W, Chintu N, Amoroso C, et al. Improving health information
systems for decision making across five sub-Saharan African coun-
tries: implementation strategies from the African Health Initiative.
BMC Health Serv Res. 2013;13(Suppl 2):S9. doi:10.1186/1472-6963-
13-S2-S9
65. African Health Observatory. African Health Observatory. Available
from: http://www.aho.afro.who.int/en. Accessed July 9, 2019.
66. World Health Organization. WHO | The Selection and Use of
Essential Medicines. WHO; 2017. Available from: http://www.who.
int/medicines/publications/essentialmedicines/trs-1006-2017/en/.
Accessed February 28, 2019.
67. Twagirumukiza M, Cosijns A, Pringels E, Remon JP, Vervaet C, Van
Bortel L. Influence of tropical climate conditions on the quality of
antihypertensive drugs from Rwandan pharmacies. Am J Trop Med
Hyg. 2009;81(5):776–781. doi:10.4269/ajtmh.2009.09-0109
68. Beran D, Yudkin JS. Looking beyond the issue of access to insulin:
what is needed for proper diabetes care in resource poor settings.
Diabetes Res Clin Pract. 2010;88(3):217–221. doi:10.1016/j.
diabres.2010.03.029
69. Beran D, Yudkin JS, de Courten M. Access to care for patients with
insulin-requiring diabetes in developing countries: case studies of
Mozambique and Zambia. Diabetes Care. 2005;28(9):2136–2140.
doi:10.2337/diacare.28.9.2136
70. Garner P. The Bamako Initiative. 1989;299. doi:10.1136/bmj.299.6
694.277
71. Manji I, Manyara SM, Jakait B, et al. The revolving fund pharmacy
model: backing up the ministry of health supply chain in western
Kenya. Int J Pharm Pract. 2016;24(5):358–366. doi:10.1111/ijpp.12
254
72. Isaacs A, Manga N, Grange CL, Hellenberg DA, Titus V, Sayed R.
Quality of care and cost of prescriptions for diabetes and hyperten-
sion at primary healthcare facilities in the Cape Town Metropole.
South Afr Fam Pract. 2015;57(3):187–193. doi:10.1080/20786190.
2014.976988
73. Mwavua SM, Ndungu EK, Mutai KK, Joshi MD. A comparative
study of the quality of care and glycemic control among ambulatory
type 2 diabetes mellitus clients, at a tertiary referral hospital and a
regional hospital in central Kenya. BMC Res Notes. 2016;9:12.
doi:10.1186/s13104-015-1826-0
74. Peck R, Mghamba J, Vanobberghen F, et al. Preparedness of
Tanzanian health facilities for outpatient primary care of hypertension
and diabetes: a cross-sectional survey. Lancet Glob Health. 2014;2
(5):e285–e292. doi:10.1016/S2214-109X(14)70033-6
75. Chamie G, Kwarisiima D, Clark TD, et al. Leveraging rapid com-
munity-based HIV testing campaigns for non-communicable diseases
in rural Uganda. PLoS One. 2012;7(8):e43400. doi:10.1371/journal.
pone.0043400
76. Janssens B, Van Damme W, Raleigh B, et al. Offering integrated care
for HIV/AIDS, diabetes and hypertension within chronic disease
clinics in Cambodia. Bull World Health Organ. 2007;85(11):880–
885. doi:10.2471/blt.06.036574
77. Azevedo M, Alla S. Diabetes in sub-saharan Africa: Kenya, Mali,
Mozambique, Nigeria, South Africa and Zambia. Int J Diabetes Dev
Ctries. 2008;28(4):101–108. doi:10.4103/0973-3930.45268
78. Kane J, Landes M, Carroll C, Nolen A, Sodhi S. A systematic review
of primary care models for non-communicable disease interventions
in sub-Saharan Africa. BMC Fam Pract. 2017;18(1):46. doi:10.1186/
s12875-017-0613-5
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress
Publish your work in this journal
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is
an international, peer-reviewed open-access journal committed to the
rapid publication of the latest laboratory and clinical findings in the
fields of diabetes, metabolic syndrome and obesity research. Original
research, review, case reports, hypothesis formation, expert opinion
and commentaries are all considered for publication. The manu-
script management system is completely online and includes a very
quick and fair peer-review system, which is all easy to use. Visit
http://www.dovepress.com/testimonials.php to read real quotes from
published authors.
Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal
Mercer et al Dovepress
submit your manuscript | www.dovepress.com
DovePress
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019:122272
